Cinven, a private equity group, announced today that it is to buy Amdipharm for 367 million pounds. Amdipharm is a family-owned niche pharmaceutical company. The intention is to merge Amdipharm ...

The group, owned by private equity firm Cinven Ltd., will access over $150 million of extra liquidity for operations with the deal, according to people familiar with the matter, who asked not to ...

Cinven has provided investment to Alter Domus to enable long-term growth of the fund administration. Cinven will work closely with Alter Domus’ founders and their significant shareholders, Permira, to ...